Logo
Chat With Us

Sevelamer Carbonate Tablets

  1. Home
  2. Sevelamer Carbonate Tablets

Sevelamer Carbonate Tablets

Categories : Nephrology & Urology

Product Packaging : 10 / 30 tablets

Product Composition : 800 mg

Sevelamer Carbonate Tablets are a non-calcium, non-metal phosphate binder indicated for the management of hyperphosphatemia in patients with chronic kidney disease (CKD), particularly those undergoing dialysis. The formulation binds dietary phosphate in the gastrointestinal tract, reducing phosphate absorption and helping maintain optimal serum phosphorus levels.

Genliva Wellness LLP offers Sevelamer Carbonate Tablets manufactured through accredited GMP-compliant facilities in India, ensuring high standards of quality, safety, and consistency. The product is developed for regulated and semi-regulated international markets, supporting nephrology-focused distribution networks and institutional supply requirements.

This formulation is widely utilized in renal care protocols, making it a key product for dialysis centers, hospitals, and specialty pharmaceutical distributors.

Send Message

Sevelamer Carbonate Tablets are a non-calcium, non-metal phosphate binder indicated for the management of hyperphosphatemia in patients with chronic kidney disease (CKD), particularly those undergoing dialysis. The formulation binds dietary phosphate in the gastrointestinal tract, reducing phosphate absorption and helping maintain optimal serum phosphorus levels.

Genliva Wellness LLP offers Sevelamer Carbonate Tablets manufactured through accredited GMP-compliant facilities in India, ensuring high standards of quality, safety, and consistency. The product is developed for regulated and semi-regulated international markets, supporting nephrology-focused distribution networks and institutional supply requirements.

This formulation is widely utilized in renal care protocols, making it a key product for dialysis centers, hospitals, and specialty pharmaceutical distributors.

  • High-quality Sevelamer Carbonate Tablets manufactured in India under stringent GMP systems
  • Effective phosphate binding capacity for CKD patient management
  • Non-calcium formulation reduces risk of hypercalcemia-related complications
  • Suitable for long-term renal therapy and dialysis patient support
  • Available in strengths such as 800 mg Sevelamer Carbonate tablets
  • Developed for consistent performance and gastrointestinal tolerability
  • Flexible options for bulk packaging, hospital supply, and branded generics
  • Supported with product documentation, stability data, and regulatory assistance
  • Ideal for international tenders and nephrology product portfolios

Sevelamer Carbonate Tablets are commonly prescribed for:

  • Management of hyperphosphatemia in CKD patients
  • Support in patients undergoing hemodialysis or peritoneal dialysis
  • Control of serum phosphate levels
  • Prevention of vascular calcification risks associated with high phosphate
  • Maintenance of mineral and bone disorder balance (CKD-MBD)
  • Adjunct therapy in advanced renal disease management
  • Tablet dosage ensures accurate phosphate-binding dose control
  • Suitable for chronic administration in renal care protocols
  • Provides consistent therapeutic action with minimal systemic absorption
  • Stable formulation supports distribution across varied climatic conditions
  • Convenient for hospital dispensing and outpatient therapy
  • Available in multiple packaging formats for global supply chains
  • Economically viable option for bulk procurement and long-term treatment programs
whatsapp-app